Company / Income Tax
Acadia Pharmaceuticals Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$252.1M
FY2025
5-year range
-$252.1M / $31.6M
FY2021-FY2025
Trend
-897.2%
vs FY2024
Sector context
#201 of 204
Health Care
What the data says
Income Tax changed -897% YoY in FY2025, a notable deviation from the 9-year average annual change of +14%.
Based on SEC 10-K filings.
-$252M in FY2025.
Improved from $10M to -$252M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 204This company -$252.1M Sector average $118.7M
▼
-312.3% below sector average
Key checks
Key Insights
- In FY2025, income tax decreased 897.2% year-over-year.
- Ranks #201 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2024.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$252.1M | -897.2% |
| FY2024 | $31.6M | +208.5% |
| FY2023 | $10.3M | +305.0% |
| FY2022 | $2.5M | +621.1% |
| FY2021 | $351.0K | -42.6% |
| FY2020 | $611.0K | -30.3% |
| FY2019 | $876.0K | -30.3% |
| FY2018 | $1.3M | +12.2% |
| FY2017 | $1.1M | -16.6% |
| FY2016 | $1.3M | +306.4% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026